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Sir,
The recent review by Joyce et  al. (2016) concludes that 
early intervention and treatment of bipolar disorder (BD) 
patients were consistently superior in 10 studies selected 
for analysis, largely involving short-term responses fol-
lowing an index episode of illness. We agree that there 
are compelling clinical reasons to encourage timely iden-
tification and treatment of such patients in efforts to limit 
long-term morbidity. However, we reported previously, 
based on 39 published reports plus original data from 
a large international sample, that neither latency from 
illness-onset nor the number of illness episodes before 
initiating treatment was related to long-term morbidity 
(percent of time ill or episodes/year) in BD subjects dur-
ing 3.8–5.4 years of treatment (Baethge et al. 2003a; Bratti 
et  al. 2003). Most of these studies were not included in 
the review by Joyce et al. (2016). We considered all sub-
jects treated at various times or following various num-
bers of recurrences, and found that long-term morbidity 
following initial treatment did not vary significantly with 
treatment-delay or episode-count.
One possible explanation for the differences in conclu-
sions arising in these studies may be caused by the lack 
of search terms more specific to the pertinent litera-
ture, such as “delay” (Baethge et  al. 2003b) or “latency” 
(Baldessarini et  al. 2003) in the overview by Joyce and 
colleagues.
Also important is a methodological problem in sev-
eral studies referred to by Joyce et  al.: comparing treat-
ment response following early versus late interventions 
is likely to compare clinically dissimilar sub-populations. 
Early intervention groups include patients with a range of 
prognoses and illness severities, whereas later interven-
tion involves subjects who have experienced illness recur-
rences and may have been exposed to various periods 
of active, failed, and discontinued treatment. That is, 
it seems likely that samples with a range of prognoses 
were compared to generally less favorable samples; such 
comparisons would be expected to yield more favorable 
initial treatment responses among early intervention sub-
jects, as was found. As examples, this confounding fac-
tor pertains to studies by Franchini et al. (1999) and Keck 
et al. (1995).
Other methodological problems include use of multi-
ple outcome measures not adjusted for multiple com-
parisons (e.g., Colom et al. 2010), as well as use of cut-off 
points selected retrospectively with risk of false-positive 
findings (e.g., Swann et  al. 1999). The fact that stud-
ies used different treatments and that some investigated 
maintenance treatment whereas others focused on acute 
treatment introduces substantial heterogeneity and adds 
to the considerable difficulties in interpreting the results.
A powerful potential motivating factor favoring early 
intervention in BD would be a “progressive” course, in 
which more-or-less euthymic intervals usually become 
shorter with a growing number of illness recurrences. 
This hypothesis, while plausible at first sight, has been 
considered repeatedly over the past century. However, 
evidence supporting it has been inconsistent and gener-
ally unfavorable; moreover, potential sampling bias has 
been noted when subjects unmatched for recurrence 
counts are compared (Oepen et  al. 2004; Baldessarini 
et al. 2012).
In conclusion, we  note that patients treated early in 
the course of BD are likely to include a proportion with 
relatively favorable responses to treatment, and fewer 
favorable cases among those with a longer history of ill-
ness and variable responses to treatment. Our previous 
findings also support the impression that some morbidity 
in BD remains during long-term treatment but that it is 
not worse after longer delay of treatment or more previ-
ous illness recurrences. This conclusion runs counter to 
current expectations that early therapeutic intervention 
in BD might lead to long-term reductions of morbidity 
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and disability superior to what can be achieved by later 
interventions. Again, this hypothesis is attractive, but it 
is far from undisputed (Duffy et al. 2016). On clinical and 
ethical grounds, we do strongly encourage timely recog-
nition and appropriate treatment of BD patients in efforts 
to limit risks of morbidity, disability, and mortality which 
can arise from prolonged and inadequately treated ill-
ness. However, the hypotheses that BD is generally pro-
gressive and that early treatment intervention can modify 
its long-term course should be considered plausible but 
unproved at this point.
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